Few questions in psychiatry are asked more often by families than this one: can a first episode of psychosis be prevented? The honest answer is layered. We cannot prevent every case. We probably cannot prevent most cases. But there is real, replicated evidence that some interventions can delay onset, soften severity, or shift the trajectory of high-risk young people. This article walks through what the science actually supports.
True prevention of first-episode psychosis is modest and uncertain — but earlier intervention reliably improves outcomes once symptoms begin.
Three levels of prevention
Public health distinguishes three kinds of prevention:
- Universal prevention — interventions delivered to everyone (clean water, vaccination)
- Selective prevention — for people at elevated risk based on group membership (e.g., children of parents with schizophrenia)
- Indicated prevention — for people already showing early symptoms but not yet meeting full diagnostic criteria (the Clinical High Risk population)
Universal prevention: limited but real
Population-wide prevention of schizophrenia is hard because risk factors are diffuse. But a few things may help at the population level:
- Reducing adolescent cannabis use — particularly high-potency cannabis, which is associated with roughly 2–4× higher risk of psychosis depending on dose and frequency (Di Forti et al., Lancet Psychiatry, 2019).
- Better obstetric care — pregnancy and birth complications are modest but measurable risk factors.
- Reducing childhood adversity — childhood trauma, particularly bullying and abuse, raises later psychosis risk.
- Maternal vitamin D and nutrition — low maternal vitamin D in pregnancy is associated with slightly higher schizophrenia risk in offspring.
Selective prevention
For young relatives of people with schizophrenia, the lifetime risk is roughly 10% (versus ~1% in the general population). No specific medication or programme has been shown to safely lower this risk in healthy relatives. The most reasonable advice — based on observational evidence — focuses on:
- Avoiding cannabis through adolescence and into the early twenties
- Treating sleep disorders aggressively
- Treating depression and anxiety early
- Maintaining strong social connections and structured activity
- Vigilance for early changes (see our guide on early warning signs)
Indicated prevention: the CHR field
Most prevention research over the last 25 years has focused on young people who already meet CHR criteria. Several intervention types have been studied:
Cognitive Behavioural Therapy
CBT for psychosis-spectrum symptoms appears to reduce transition rates modestly. The EDIE-2 trial (Morrison et al., BMJ, 2012) showed reduced symptoms over 24 months but no statistically significant difference in transition rates. A meta-analysis by Davies et al. (Schizophrenia Bulletin, 2018) found a small but consistent benefit when CBT was compared with treatment as usual.
Omega-3 fatty acids
The 2010 Vienna trial by Amminger and McGorry suggested that fish-oil omega-3 reduced transition to psychosis. Subsequent larger trials (NEURAPRO, 2017) did not replicate the effect. See our dedicated piece on the McGorry omega-3 trial for the full story.
Antipsychotic medication
Several trials have asked whether low-dose antipsychotics in CHR could prevent transition. The findings are mixed, and most guidelines (including NICE CG178) explicitly recommend against using antipsychotics as a preventive intervention in CHR — the side-effect burden is substantial and the long-term benefit is unclear.
Family intervention and integrated care
Multimodal early intervention services, including family work and case management, appear to reduce transition rates in some studies. The effects are modest but consistent.
What the field is moving toward
Recent thinking, including from the international Early Psychosis Declaration supported by the WHO and Patrick McGorry's group, has shifted away from "predicting and preventing schizophrenia" toward improving the long-term trajectory of any young person with sub-threshold symptoms. This transdiagnostic, staged-care approach treats current distress aggressively and watches for progression, rather than betting everything on transition prediction.
Where Frida and digital tools fit
Digital monitoring tools have a modest but useful role. Apps like Frida and other digital therapeutics can track sleep, mood, and early warning signs over time, giving clinicians and families an objective baseline. They are not preventive treatments themselves, but they may help shorten the duration of untreated psychosis by spotting early changes faster.
An honest summary for families
If your child or sibling is at higher risk, what you can reasonably do:
- Get them connected to a CHR clinic if symptoms emerge
- Help them avoid cannabis through their early twenties
- Treat sleep disorders, anxiety, and depression promptly
- Keep them engaged in school, work, and social life
- Watch for early warning signs without surveilling
- Learn the local coordinated specialty care options now, before you need them
None of this guarantees prevention. All of it improves the odds, and all of it improves what happens if a first episode does occur.
The future
Several promising lines of research are open: TMS in CHR, anti-inflammatory medications, advanced biomarker panels, and digital-phenotyping early-warning systems. A truly preventive treatment for psychosis would be one of the great public-health achievements of this century. We are not there yet — but we are closer than we were a generation ago, and the people working on it deserve a great deal of patience and hope.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.